| 2007 |
Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. February 2007;40(2):251-264. |
22 |
22 |
| 2022 |
Schett G, Takayanagi H. Editorial overview: osteoimmunology. Bone. September 2022;162:116466. |
0 |
0 |
| 2023 |
Okamoto K, Takayanagi H. Effect of T cells on bone. Bone. March 2023;168:116675. |
0 |
0 |
| 2002 |
Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J-i, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. December 1, 2002;3(6):889-901. |
30 |
29 |
| 2011 |
Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. October 2011;17(10):1231-1234. |
81 |
78 |